Stock listing

Astellas Pharma Inc.

Selected listing: YPH · HAM · EUR · DE

Astellas Pharma Inc. (Hamburg:YPH), Health Technology. Latest release Oct 6, 2026: Astellas Highlights Data Advancing Cancer Care and Innovation for Patients…

YPH:HAMEURDEUpdated September 26, 2026

Ticker: Hamburg:YPH
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Hamburg
Currency: EUR

Latest news from Astellas Pharma Inc.

Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026

October 6, 2026

Astellas Doses First Patient in Phase 3 Study of setidegrasib in Previously Treated KRAS G12D-Mutated Advanced Non-Small Cell Lung Cancer

September 23, 2026

Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer

September 1, 2026

Astellas enters voluntary agreement with U.S. government supporting affordable access to medicines

August 31, 2026

Astellas Doses First Patient in Phase 3 Study of ASP2138 in CLDN18.2-postive and HER2-negative locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma

August 24, 2026

All Astellas Pharma Inc. news →

Events

Replays

Astellas Pharma Inc (ALPMF) Q4 2025 Earnings Call
Mon, Apr 27, 2026 · 02:30 AM ET
Watch
Astellas Pharma Inc (ALPMF) Q3 2025 Earnings Call
Fri, Feb 06, 2026 · 02:00 AM ET
Watch
Astellas Pharma Inc (ALPMF) Q2 2025 Earnings Call
Thu, Oct 30, 2025 · 02:30 AM ET
Watch

Research Astellas Pharma Inc.

Astellas Pharma Inc. company profile

View the public company page for Astellas Pharma Inc. on 6ix.

Astellas Pharma Inc. news

Read company news and market updates connected to Astellas Pharma Inc..

Astellas Pharma Inc. investor events

Find investor webinars, events, and replay context for Astellas Pharma Inc..